Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.

Patricia Palau, Julia Seller, Eloy Domínguez, Clara Sastre, Jose María Ramón, Rafael de La Espriella, Enrique Santas, Gema Miñana, Vicent Bodí, Juan Sanchis, Alfonso Valle, F Javier Chorro, Pau Llácer, Antoni Bayés-Genís, Julio Núñez

November 2021 J Am Coll Cardiol

Synopsis of Social media discussions

The overall tone suggests strong support and curiosity about the study's implications, exemplified by phrases like

A
Agreement
 Moderate agreement

Most discussions acknowledge that withdrawing beta-blockers may improve functional capacity in HFpEF, showing general support for the study's findings.

I
Interest
 High level of interest

The discussions demonstrate high interest, with many references to the latest research, ongoing debates, and potential changes in clinical practice.

E
Engagement
 High engagement

Posts reference specific studies, trial outcomes, and implications for treatment, indicating deep engagement with the research.

I
Impact
 Moderate level of impact

While some highlight the potential for practice changes, others emphasize ongoing research and debate, so the perceived impact is moderate but significant.

Social Mentions

YouTube

3 Videos

Facebook

5 Posts

Twitter

209 Posts

Blogs

2 Articles

News

3 Articles

Metrics

Video Views

111

Total Likes

718

Extended Reach

739,698

Social Features

222

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Impact of Beta-Blocker Withdrawal on Exercise Capacity in HFpEF Patients

Impact of Beta-Blocker Withdrawal on Exercise Capacity in HFpEF Patients

This study investigated how stopping blockers affects exercise capacity in patients with heart failure with preserved ejection fraction and chronotropic incompetence, showing that withdrawing blockers significantly improved peak oxygen consumption.

Medscape

March 27, 2024

69 views

Blood Flow Imaging in Cardiology: Coronary CTA Reduces 5-Year Heart Attack Risk

Blood Flow Imaging in Cardiology: Coronary CTA Reduces 5-Year Heart Attack Risk

A multicenter trial with 4146 patients found that adding coronary CT angiography to standard care reduced the 5-year risk of death from coronary heart disease or nonfatal myocardial infarction, improving patient outcomes with comparable invasive procedure rates.

Medscape

March 27, 2024

27 views

Innovative Approaches in Managing Heart Failure with Preserved Ejection Fraction

Innovative Approaches in Managing Heart Failure with Preserved Ejection Fraction

This week's cardiology update covers new insights into diastolic dysfunction, HFpEF, MRI scanning, and treatments such as accelerated pacing and blocker withdrawal, emphasizing personalized strategies to improve patient outcomes in HFpEF.

Medscape

March 27, 2024

15 views

  • おちば@腎臓内科
    @autumnleaveskid (Twitter)

    「変時不全（chronotropic incompetence）」っていう概念を今更ながら初めて知った！ β遮断→適切に脈拍数が増えない→運動機能の低下 ってことがあるらしい。 HFpEF患者へのβはエビデンス乏しいのは有名だけど、患者さんによっては害になりうるかもしれない…！
    view full post

    October 26, 2025

    4

  • Juan Pedro Romero
    @JuanPedroRome20 (Twitter)

    RT @JuliaSellerm:
    view full post

    March 2, 2024

    1

  • Julia Seller
    @JuliaSellerm (Twitter)


    view full post

    February 8, 2024

    6

    1

  • せのー
    @senyooo (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    May 3, 2023

    31

  • Sanjiv J. Shah, MD
    @HFpEF (Twitter)

    @abdelhamed012 Many pts with HFpEF have inability to increase stroke volume with exercise so depend on ⬆️HR to augment CO. And BB withdrawal trial showed benefit in HFpEF (https://t.co/2DJkLyAvRj). NEAT-HFpEF nitrate trial in HFpEF: no benefit to possible harm: https://t.co/umqZqmWOm6
    view full post

    April 21, 2023

    4

    1

  • Sanjiv J. Shah, MD
    @HFpEF (Twitter)

    @AAmin_cardio Carvedilol is a great anti-HTN drug given its BB, alpha-block, and CCB properties (https://t.co/jVFgbrthVl), it's like a polypill. I used to use if all the time. COHERE registry supported its use in HFpEF. But recent BB withdrawal trial showed benefit: https://t.co/2DJkLyAvRj
    view full post

    April 21, 2023

  • Jorge Mario
    @piedrux (Twitter)

    RT @CardioCaribeMx: #Competencia #cronotropica Multicéntrico clínico cruzado Px FEVI conservada 2 sem con retiro (o no) de beta-bloqueador…
    view full post

    March 31, 2023

    1

  • Cardiopaps
    @CardioCaribeMx (Twitter)

    #Competencia #cronotropica Multicéntrico clínico cruzado Px FEVI conservada 2 sem con retiro (o no) de beta-bloqueador Después de 2 sem la intervención opuesta Promedio 72 â, 60% ♀️ Pico #VO2 12.4 mlkgmin Al retiro ⬆️ VO2 a 14.3 mlkgmin DOI: 10.1016/j.jacc.2021.08.073 https://t.co/QEu84GECe3
    view full post

    March 31, 2023

    1

    1

  • k
    @GV2aUF (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    March 26, 2023

    31

  • りるあり
    @heart_rhythms (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    March 10, 2023

    31

  • Prabhakar Dorairaj
    @prabhud19 (Twitter)

    @shivadas29 @SABOURETCardio @NeeChe @lipo_fan https://t.co/ZiOohITnjj
    view full post

    March 2, 2023

    2

  • Ash Paul
    @pash22 (Twitter)

    RT @nrajag: @drjohnm @gcfmd @JavedButler1 @MaggieInfeld Yes, more recently there has been discussion that beta blockers are overused in HFp…
    view full post

    February 7, 2023

    1

  • Mazen Albaghdadi MD MSc
    @malbag1 (Twitter)

    what is the long term effect of chronic RV pacing in patients with AF and HFpEF? time for a large outcomes-based RCT of beta blockers in HFpEF? https://t.co/ChlgK7eu6i
    view full post

    February 4, 2023

    1

  • Navin Rajagopalan
    @nrajag (Twitter)

    @drjohnm @gcfmd @JavedButler1 @MaggieInfeld Yes, more recently there has been discussion that beta blockers are overused in HFpEF. See this paper: Palau P, Seller J, Domínguez E, et al. Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. https://t.co/KWABdnkHC8
    view full post

    February 2, 2023

    3

    1

  • Piotr Lech
    @piotr_lech (Twitter)

    @drjohnm @gcfmd @JavedButler1 @MaggieInfeld I saw this a while ago... May be related https://t.co/LdLQaRxGku
    view full post

    February 2, 2023

    1

  • Liza Kokhan
    @kokhhan (Twitter)

    @drjohnm @JAMACardio @lusty63 It’s possible that reason is in unfavourable effect of slowing HR in HFpEF (especially with BBs - negative lusitropy, DD progression, chronotropic incompetence). https://t.co/dtf2FS46qW and https://t.co/8ElE6MwZjw. But interesting that frequency of BB use in HFpEF is still ~80%…
    view full post

    February 1, 2023

    3

  • Ryan J Tedford MD
    @RyanTedfordMD (Twitter)

    @GaneshMuthappan @MarkusMeyerMD @DNSilvermanMD @MaggieInfeld @JAMACardio I do. Very few HFpEF pts with absolute indications for BB use. And some suggestions of harm: https://t.co/i0oaHwJcrZ https://t.co/9ETlEljyyz
    view full post

    February 1, 2023

    6

  • Nelson murillo
    @nemurillob (Twitter)

    RT @ValleAlfonso: El trabajo y la constancia = éxito
    view full post

    January 26, 2023

    5

  • juan lopez
    @jd1lopez (Twitter)

    RT @ValleAlfonso: El trabajo y la constancia = éxito
    view full post

    January 25, 2023

    5

  • Patrícia Palau
    @PatriciaPalau1 (Twitter)

    RT @ValleAlfonso: El trabajo y la constancia = éxito
    view full post

    January 25, 2023

    5

  • Edgardo Alania
    @Ed_Alania (Twitter)

    RT @ValleAlfonso: El trabajo y la constancia = éxito
    view full post

    January 25, 2023

    5

  • Rafael de la Espriella
    @rdelaespriella (Twitter)

    RT @ValleAlfonso: El trabajo y la constancia = éxito
    view full post

    January 25, 2023

    5

  • Alfonso Valle
    @ValleAlfonso (Twitter)

    El trabajo y la constancia = éxito
    view full post

    January 25, 2023

    84

    5

  • たご
    @gyomutago (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    January 22, 2023

    31

  • こぺ
    @kopeMed (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    January 21, 2023

    31

  • levanlam
    @levanlam0202 (Twitter)

    Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction https://t.co/I9D7e708Gt
    view full post

    December 24, 2022

  • ZALLA
    @zalda8600 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 21, 2022

    31

  • Akira Mizukami@EP University Ablation School
    @akmizukami (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 18, 2022

    31

  • ヤマザキ
    @Fe_yamazaki (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 18, 2022

    31

  • Takuya Kishi @ねこ好き循環器内科医
    @tkishi_cardiol (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 18, 2022

    31

  • M.A
    @traumareporter (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 18, 2022

    31

  • つゆかんX
    @tsuyukan56 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • Massaman Suga.
    @MasatakaMd (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • 塚越大智 / Daichi Tsukakoshi
    @tsukakoshi_ot (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • あこ@循環器内科
    @asaaoki (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • nicoca
    @nicyoka (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • kk
    @kota1418 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • G.S CL
    @XiXgyuGQp65QGYC (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • ただひと
    @VTI15436341 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • IWASHIMA Satoru岩島覚.MD, PhD.ﾔｰ
    @SIwa23288585 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • はぎ
    @hagi220 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • まめたろう,MD, PhD
    @mameeps (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • sentokun
    @sentokunpcs (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • Morio
    @MorioOno1 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 17, 2022

    31

  • TSUJISHIN
    @TSUJISHIN0207 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 16, 2022

    31

  • Tetsuma Kawaji, MD, PhD. FJCC/川治徹真
    @tetsumaK1 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 16, 2022

    31

  • ロジック。
    @rozic_3276 (Twitter)

    RT @JSE_JAYEF: 左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要…
    view full post

    December 16, 2022

    31

  • 若手心エコーフェローの会-JAYEF-
    @JSE_JAYEF (Twitter)

    左室駆出率の保持された心不全(HFpEF)では、evidenceがないにも関わらず、β-blockerが頻用されています。運動時の心拍応答不全を有するHFpEF患者のβ-blocker中止は運動耐容能を改善すると報告され、同薬の使用を見つめ直す必要がありそうです。 https://t.co/FFqLKVINUM # HFpEF # β-blocker https://t.co/GYVjNoePbx
    view full post

    December 16, 2022

    203

    31

  • Carmen Rus
    @crusmansilla (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Hospital Clínic de València
    @GVAclinic (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Juan Izquierdo García
    @Juan__Izquierdo (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Pau Llàcer
    @paullaceriborra (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Julio
    @yulnunezvill (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Matthew-qiao
    @Matthew_Qiao (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Julia Seller
    @JuliaSellerm (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Javier de Juan
    @JavierdeJuan1 (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Grupo Trabajo Ergoespirometría SEC
    @Ergoespiro_SEC (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Rosa Fernandez
    @MAROSFO (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • Unidad Ic Hospital Clínico
    @IcUnidad (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 26, 2022

    12

  • MutualMédica
    @MutualMedica (Twitter)

    RT @PatriciaPalau1: Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functio…
    view full post

    November 25, 2022

    12

  • Patrícia Palau
    @PatriciaPalau1 (Twitter)

    Gracias a la fundación @MutualMedica por el reconocimiento a nuestro trabajo “Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction”. Un orgullo recogerlo en representación de @yulnunezvill @EloyDomnguez6 @JuliaSellerm https://t.co/iiPbF1YhtC
    view full post

    November 25, 2022

    70

    12


  • @rmohty (Twitter)

    @kidney_boy https://t.co/2R4hJBSC5R
    view full post

    September 25, 2022

    1

  • Faby G.
    @Fabiolaghh (Twitter)

    RT @CardioRoland: @gcfmd @HFSA @JavedButler1 @paheidenreich @JCardFail @texhern In contrast, betablockers in HFPEF decrease QoL…another rea…
    view full post

    July 3, 2022

    2

  • Hector GSM
    @hrgsantamaria (Twitter)

    RT @CardioRoland: @gcfmd @HFSA @JavedButler1 @paheidenreich @JCardFail @texhern In contrast, betablockers in HFPEF decrease QoL…another rea…
    view full post

    July 2, 2022

    2

  • cardio Roland
    @CardioRoland (Twitter)

    @gcfmd @HFSA @JavedButler1 @paheidenreich @JCardFail @texhern In contrast, betablockers in HFPEF decrease QoL…another reason to avoid them in HFPEF https://t.co/Msa7Y6kKZ1
    view full post

    July 2, 2022

    8

    2

  • Patrícia Palau
    @PatriciaPalau1 (Twitter)

    RT @CardioRoland: @mvaduganathan @gcfmd @naderjo In fact: withdrawing them improves QoL. Improvement of QoL is an endpoint we, physicians t…
    view full post

    May 29, 2022

    1

  • cardio Roland
    @CardioRoland (Twitter)

    @mvaduganathan @gcfmd @naderjo In fact: withdrawing them improves QoL. Improvement of QoL is an endpoint we, physicians tend to underestimate when compared to mortality or rehospitalisation in our prescription process… https://t.co/d4ynxJsISQ
    view full post

    May 29, 2022

    2

    1

  • Alex Reyentovich, MD
    @ReyentovichHFMD (Twitter)

    Thank you Dr. Nunez for presenting your important work to the ⁦@nyulangone⁩ Advanced Heart Failure Journal Club helping us eloquently understand the negative impact of beta blocker use in patients with HFPEF https://t.co/Av3EJ7lllq
    view full post

    January 14, 2022

    1

  • David Winchester @drdavemd.bsky.social
    @drdavemd (Twitter)

    I have lost track of how many patients with dyspnea/fatigue feel better after discontinuing unnecessary beta blocker treatment https://t.co/bRZRBz64fk #cardiotwitter
    view full post

    January 10, 2022

    3

  • Mazhar
    @MERAJSAIF (Twitter)

    RT @ValleAlfonso: Thanks to @PatriciaPalau1 @JuliaSellerm @SantasEnrique @yulnunezvill @rdelaespriella @gema_minana @IcUnidad @HospitaldeDe…
    view full post

    January 5, 2022

    14

  • Omar M. Abdelfattah, MD, FESC
    @AbdelfattahMD (Twitter)

    RT @ValleAlfonso: Thanks to @PatriciaPalau1 @JuliaSellerm @SantasEnrique @yulnunezvill @rdelaespriella @gema_minana @IcUnidad @HospitaldeDe…
    view full post

    January 5, 2022

    14

  • Miguel Turégano
    @tureyedro (Twitter)

    RT @MGol_MD: @SeguraCardio @JCardFail @robmentz @dranulala @j_alvarezgarcia @paomorejon @HFpEF @gcfmd @ShelleyZieroth @IcyfaSemi @SIAC_card…
    view full post

    December 28, 2021

    1

  • Milad Golabkesh
    @MGol_MD (Twitter)

    @SeguraCardio @JCardFail @robmentz @dranulala @j_alvarezgarcia @paomorejon @HFpEF @gcfmd @ShelleyZieroth @IcyfaSemi @SIAC_cardio Great overview! Maybe as therapeutic add-ons, titrating down beta-blockers (if no other reasons of use such as Afib etc) and SGLT2-Inhibitor utilization. Sources: 1) https://t.co/TaOsQmEdWT 2) https://t.co/NEMZHPFoWc
    view full post

    December 27, 2021

    4

    1

  • Todd C. Lee
    @DrToddLee (Twitter)

    @DavidLBrownMD @purviparwani Why not taper the beta blocker? Because the EF is still 50% and not 60%? I think that alone will improve QOL enough that he would agree to keep the rest of the drugs https://t.co/4PVkMZjkBT
    view full post

    December 14, 2021

    1

  • Manuel Abeytua
    @AbeytuaManuel (Twitter)

    RT @JuliaSellerm: 4️⃣ PRESERVE-HR
    view full post

    December 9, 2021

    2

  • Lorenzo Bertomeu
    @BertomeuLorenzo (Twitter)

    RT @almucastro01: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction Enhorabuena (aga…
    view full post

    December 8, 2021

    6

  • Juan Carlos Obaya
    @jcobaya69 (Twitter)

    RT @JuliaSellerm: 4️⃣ PRESERVE-HR
    view full post

    December 8, 2021

    2

  • Julia Seller
    @JuliaSellerm (Twitter)

    4️⃣ PRESERVE-HR
    view full post

    December 8, 2021

    14

    2

  • Julia Seller
    @JuliaSellerm (Twitter)


    view full post

    November 28, 2021

    3

  • Grupo Investigación Multidisciplinar Extremeño
    @GRIMEX_ (Twitter)

    Beta bloqueantes en pacientes con FEVIp e insuficiencia cronotropica @jaccjournals https://t.co/Ljvc5C5QbD
    view full post

    November 28, 2021

  • Jeremy S. Pollock
    @bmorecardiology (Twitter)

    Physiology makes sense.. No atrial kick, diastole doesn't help, less diastole = improved symptoms. Take the BB in HFpEF? Probably. #PRESERVE-HR https://t.co/Y5eg6zmwT9 https://t.co/8lX9FRM4iA
    view full post

    November 22, 2021

  • Luis Davalos CARDIOLOGIA
    @KKATODD (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 21, 2021

    20

  • IANCARDIOLOGY
    @CardioIAN (Twitter)

    @CardioIAN #CardioTwitter https://t.co/oqXDvmrs06
    view full post

    November 21, 2021

  • Omar M. Abdelfattah, MD, FESC
    @AbdelfattahMD (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Jerónimo Xavier Cassanello
    @xass76 (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Hiroyuki Okura, MD(大倉宏之)
    @HiroyukiOkura (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Dirk Westermann
    @dirkwestermann (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Umut Kocabaş
    @UmutKocabasMD (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Prof Marwan Refaat
    @DrMarwanRefaat (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Pedro Schwartzmann, MD, PhD, FESC
    @pedschwartzmann (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Hatice Kemal
    @HaticeKGunsel (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Enrique Santas
    @SantasEnrique (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Prof Chris P Gale
    @cpgale3 (Twitter)

    In patients with #HFpEF & chronotropic incompetence, β-blocker withdrawal resulted in short-term improvement in peak Vo2 ⁦@JACCJournals⁩ https://t.co/r6WkyNPFDV
    view full post

    November 21, 2021

    4

  • Surenjav Chimed
    @surenjav_ch (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Fernando Civeira
    @FernandoCiveir1 (Twitter)

    RT @JACCJournals: Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and…
    view full post

    November 21, 2021

    31

  • Ian medical
    @IanMedical (Twitter)

    RT @GermanECediel: Retirar para mejorar — estudio aleatorizado que demuestra que retirar betabloqueantes en HFpEF mejora el consumo de oxíg…
    view full post

    November 21, 2021

    6

  • JACC Journals
    @JACCJournals (Twitter)

    Editors’ Insights: Is it time for us to re-evaluate beta blocker use in #HFpEF? New research suggests it may not help and possibly even hinder some patients: Do you agree? Let us know in the comments below! https://t.co/j7LtgoLoEf #JACC #CardioTwitter #HeartFailure #SportsCardio https://t.co/2ksxZcgSjC
    view full post

    November 21, 2021

    112

    31

  • Lorenzo Bertomeu
    @BertomeuLorenzo (Twitter)

    RT @GermanECediel: Retirar para mejorar — estudio aleatorizado que demuestra que retirar betabloqueantes en HFpEF mejora el consumo de oxíg…
    view full post

    November 21, 2021

    6

  • Italo Kumamoto
    @fikkumamoto (Twitter)

    RT @GermanECediel: Retirar para mejorar — estudio aleatorizado que demuestra que retirar betabloqueantes en HFpEF mejora el consumo de oxíg…
    view full post

    November 21, 2021

    6

  • HUGO COLOMBO MD
    @HCOLOMBO1958 (Twitter)

    RT @GermanECediel: Retirar para mejorar — estudio aleatorizado que demuestra que retirar betabloqueantes en HFpEF mejora el consumo de oxíg…
    view full post

    November 21, 2021

    6

  • Rene Rodriguez
    @renecardio4 (Twitter)

    RT @GermanECediel: Retirar para mejorar — estudio aleatorizado que demuestra que retirar betabloqueantes en HFpEF mejora el consumo de oxíg…
    view full post

    November 21, 2021

    6

  • juan lopez
    @jd1lopez (Twitter)

    RT @GermanECediel: Retirar para mejorar — estudio aleatorizado que demuestra que retirar betabloqueantes en HFpEF mejora el consumo de oxíg…
    view full post

    November 21, 2021

    6

  • Plper
    @periopTTEcho (Twitter)

    RT @SeguraCardio:
    view full post

    November 21, 2021

    38

  • German E Cediel
    @GermanECediel (Twitter)

    Retirar para mejorar — estudio aleatorizado que demuestra que retirar betabloqueantes en HFpEF mejora el consumo de oxígeno. ¿Aplica para todos los pacientes? Excelente campo de investigación @yulnunezvill https://t.co/0zh1ZXptrf https://t.co/AnG3nM7suH
    view full post

    November 21, 2021

    19

    6

  • Pedro Moliner
    @PeterMoliner (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 20, 2021

    62

  • pinacol
    @pinacol (Twitter)

    【クロスオーバー試験】NYHA分類II-IIIでβ遮断薬による治療歴、変時性不全がある安定したHFpEF患者でのβ遮断薬の中止は、Peak Vo2およびPeak Vo2%を改善させた。 #ペ読 https://t.co/sbjOAmmHjm
    view full post

    November 19, 2021

    1

  • Lorenzo Bertomeu
    @BertomeuLorenzo (Twitter)

    RT @almucastro01: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction Enhorabuena (aga…
    view full post

    November 19, 2021

    6

  • Olli Kantola
    @KantolaOlli (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 19, 2021

    20

  • Agnieszka Kaplon-Cieslicka
    @KaplonCieslicka (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 19, 2021

    20

  • Francisco Rios
    @fjrios92 (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 19, 2021

    20

  • Dr. Perez-Belmonte
    @belmonte_dr (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 19, 2021

    20

  • Ricardo Esquivel
    @richares_ (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 19, 2021

    20

  • Phattararuethai S. MD
    @pukchii3 (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 18, 2021

    20

  • Raul Villar
    @DrRaulvillar (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 18, 2021

    20

  • Arif Cavadov
    @CavadovArif (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 18, 2021

    20

  • David Reina Hoyos
    @davidreinah (Twitter)

    RT @drdquesada: El siempre difícil tratamiento de la insuficiencia cardíaca con fracción preservada. Medicina precisión. ⬇️⬇️ Beta bloq me…
    view full post

    November 18, 2021

    7

  • Laura Núñez Martínez
    @Laurynumar (Twitter)

    RT @drdquesada: El siempre difícil tratamiento de la insuficiencia cardíaca con fracción preservada. Medicina precisión. ⬇️⬇️ Beta bloq me…
    view full post

    November 18, 2021

    7

  • Joan Albert Barberà
    @J_AlbertBarbera (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 18, 2021

    20

  • Jorge Zavaleta
    @zavacdv (Twitter)

    RT @drdquesada: El siempre difícil tratamiento de la insuficiencia cardíaca con fracción preservada. Medicina precisión. ⬇️⬇️ Beta bloq me…
    view full post

    November 18, 2021

    7

  • irene rilo
    @irilomiranda (Twitter)

    RT @HanCardiomd: PRESERVE-HR β-blocker withdrawal improved maximal functional capacity in patients with #HFpEF and chronotropic incompete…
    view full post

    November 18, 2021

    20

  • Virginia Ramos Reyes
    @VirginiaRamosRy (Twitter)

    RT @SeguraCardio:
    view full post

    November 18, 2021

    38

  • Lowellfletchermd
    @Lowellfletcher8 (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 18, 2021

    26

  • MashupMD
    @MdMashup (Twitter)

    Today's top #cardiology headline comes from @JACCJournals. #HeartFailure #cardiotwitter https://t.co/clvpk4yp68
    view full post

    November 17, 2021

    1

  • Fernando Rodriguez
    @recetario1 (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 17, 2021

    26

  • Rosa Fernandez
    @MAROSFO (Twitter)

    RT @SeguraCardio:
    view full post

    November 17, 2021

    38

  • Telaraña Farmacéutica
    @telarfarma (Twitter)

    RT @SeguraCardio:
    view full post

    November 17, 2021

    38

  • Zainab Dakhil
    @ZainabDakhil2 (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Luis H
    @luishermejMD (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • HUGO COLOMBO MD
    @HCOLOMBO1958 (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Canadian Heart Failure Society
    @CanHFSociety (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Sinisa T Zivkovic
    @dragonpn07 (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Dr. Máté
    @milena_mate (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Joan Albert Barberà
    @J_AlbertBarbera (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • David Hassel
    @hassel_d (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • alamekarim
    @alamekarim1 (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Marco Vicenzi
    @VicenziMarco (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Italo Kumamoto
    @fikkumamoto (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Cardiopaps
    @CardioCaribeMx (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Paula G. Bores
    @paula7737 (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • P. Binder.
    @pbinders (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Dr. Oriba Dan Langoya
    @DrOribaDan (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Ali Alhussainy MD
    @Agathusia97 (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Hany Ragy
    @Hragy (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Manu Morales Sánchez
    @Manugrillo2 (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Basel Alenazy | باسل العنزي
    @Baselalanazi6 (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • @MARTINSVEL
    @MARTINSVEL (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Jason H. Wasfy, M.D.
    @jasonwasfy (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • @MARTINSVEL
    @MARTINSVEL (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Kaushik K. Jain
    @drkaushikjain (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Daisuke Kamimura
    @Daisukekmmr (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Marco Ochs, MD FACC FESC
    @MMOCHS (Twitter)

    RT @SeguraCardio:
    view full post

    November 16, 2021

    38

  • Dr Benchetrit
    @shemybenchetrit (Twitter)

    RT @SeguraCardio:
    view full post

    November 16, 2021

    38

  • Philippe B. Bertrand
    @Ph_Bertrand (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Osama Bisht
    @Obisht (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Dr. Agustín T Guzman
    @nitzuga7 (Twitter)

    RT @SeguraCardio:
    view full post

    November 16, 2021

    38

  • Karsten Schenke
    @kaschenke (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Timm Bauer
    @BauerTimm (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Ryan J Tedford MD
    @RyanTedfordMD (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Hassan Irshad Bajwa
    @hassaanbajwaa (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • ᗯᗩᒪEEᗪ Eᒪ-ᗩᗯᗩᗪY
    @wal75card (Twitter)

    Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction | Journal of the American College of Cardiology https://t.co/XnJcB9yjo0
    view full post

    November 16, 2021

  • Giuseppe Biondi-Zoccai
    @gbiondizoccai (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Shailendra (Shai) Upadhyay
    @supadhyaymd (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • exlocus
    @exlocus (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Rubén Fernández
    @Rbn_Fernandez (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Marcelo Ramalho
    @marceloramalho (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Rosario Mármol
    @_rMarmol_ (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Dr Anastasia Mihailidou FAHA FCSANZ FESC
    @AnastasiaSMihai (Twitter)

    RT @SeguraCardio:
    view full post

    November 16, 2021

    38

  • Ana Neto
    @ananeto16 (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Eduardo Enriquez
    @EnriquezEdwardo (Twitter)

    RT @SeguraCardio:
    view full post

    November 16, 2021

    38

  • Yevgeniy Brailovsky DO MSc FACC
    @YevgeniyBr (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Carlos Cabrera Arroyo
    @cabrera_arroyo (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Jose Luis Górriz
    @jlgorriz (Twitter)

    RT @almucastro01: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction Enhorabuena (aga…
    view full post

    November 16, 2021

    6

  • rafavidalperez
    @rafavidalperez (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Alejandro Avila
    @Avila_MD (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Aleix Olivella
    @AleixOlivella (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Alessia Argiró
    @AlessiaArgiro (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • @load-depentent.bsky.social
    @load_dependent (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Manu Morales Sánchez
    @Manugrillo2 (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Raul Fonseca
    @Rulex74c (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Elena Romero
    @eromerodorta (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Lin Weiqin
    @weiqin_lin (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Mavi Farré Mercadé
    @mavifarre (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 16, 2021

    21

  • Dr. Diggi Sharanbasu
    @SharanDiggi (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Gonzalo L Alonso Salinas
    @Gontxi7 (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 16, 2021

    62

  • Keith Andrew Chan, MD
    @keithachanmd (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Stephen Wright, PhD
    @TheWrightHeart (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 16, 2021

    26

  • Dr. L
    @Dr__ELE (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • Francisco Soto, MD, MS, MBA
    @FSotoMD (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 15, 2021

    26

  • Sol
    @ArualSogar (Twitter)

    RT @almucastro01: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction Enhorabuena (aga…
    view full post

    November 15, 2021

    6

  • Dr. Jullo
    @F_Trujillo90 (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • sporcukalpdoktoru
    @sporcukalpdr (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • Rodney Samaan
    @rsamaan (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 15, 2021

    21

  • Alexander Hajduczok, MD
    @AHajduczok (Twitter)

    RT @AndrewJSauer: “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart…
    view full post

    November 15, 2021

    26

  • Andrew J Sauer MD
    @AndrewJSauer (Twitter)

    “β-blocker use in HFpEF deserves profound re-evaluation” Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction | Journal of the American College of Cardiology https://t.co/vqDiy3nITK
    view full post

    November 15, 2021

    89

    26

  • Kaushik K. Jain
    @drkaushikjain (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • Arturo Aleman
    @ElArturoAleman (Twitter)

    RT @SeguraCardio:
    view full post

    November 15, 2021

    38

  • Dr.Mughal
    @mughal381 (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • Dr.Mughal
    @mughal381 (Twitter)

    RT @SeguraCardio:
    view full post

    November 15, 2021

    38

  • diego romero cawen
    @chinorigin (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • Pablo Cimbaro Canell
    @PabloCimbaro (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • Lorenzo Bertomeu
    @BertomeuLorenzo (Twitter)

    RT @SeguraCardio:
    view full post

    November 15, 2021

    38

  • Lorenzo Bertomeu
    @BertomeuLorenzo (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • juan lopez
    @jd1lopez (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • pramesh gaidhane
    @pramesh0522 (Twitter)

    RT @JuliaSellerm: Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. Preserve-HR trial…
    view full post

    November 15, 2021

    62

  • José Miguel Torres Viera
    @torresviera (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 15, 2021

    21

  • Josh Wilcox
    @jdrwilcox (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 15, 2021

    21

  • Raj Mehta
    @raj_mehta (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 15, 2021

    21

  • Toby Markowitz
    @tobymarkowitz (Twitter)

    RT @OAB1967: The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3k…
    view full post

    November 15, 2021

    21


  • @OAB1967 (Twitter)

    The wrong drug for a complex disease? ß-Blocker withdrawal improves functional exercise capacity in HFpEF https://t.co/cLQhu3kgrA @BerrischR @Ch_Stumpf @AG32_DGK @AG14_DGK @ChristianRost10 @drjohnm https://t.co/z1EmGIZ6Ye
    view full post

    November 15, 2021

    66

    21

Abstract Synopsis

  • This study investigated how stopping blockers affects exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence, showing that withdrawing blockers significantly improved peak oxygen consumption.
  • The trial was a multicenter, randomized crossover designed to compare the effects of continued treatment versus withdrawal, revealing that patients' maximal functional capacity increased after stopping blockers.
  • Overall, the findings suggest that discontinuing blockers may enhance exercise ability in HFpEF patients with chronotropic issues, indicating a need to reconsider the routine use of blockers in this population.